HuGE Literature Finder
Records
1
-
3
Impact of somatic and germline mutations on the outcome of systemic mastocytosis. Blood advances 2018 11 2 (21): 2814-2828. Muñoz-González Javier I, Jara-Acevedo María, Alvarez-Twose Iván, Merker Jason D, Teodosio Cristina, Hou Yanli, Henriques Ana, Roskin Krishna M, Sanchez-Muñoz Laura, Tsai Albert G, Caldas Carolina, Matito Almudena, Sánchez-Gallego J Ignacio, Mayado Andrea, Dasilva-Freire Noelia, Gotlib Jason R, Escribano Luis, Orfao Alberto, García-Montero Andrés |
Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event. Leukemia 2015 May 29 (5): 1115-22. Jawhar M, Schwaab J, Schnittger S, Sotlar K, Horny H-P, Metzgeroth G, Müller N, Schneider S, Naumann N, Walz C, Haferlach T, Valent P, Hofmann W-K, Cross N C P, Fabarius A, Reiter |
Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis. PloS one 2012 7 (8): e43090. Traina Fabiola, Visconte Valeria, Jankowska Anna M, Makishima Hideki, O'Keefe Christine L, Elson Paul, Han Yingchun, Hsieh Fred H, Sekeres Mikkael A, Mali Raghuveer Singh, Kalaycio Matt, Lichtin Alan E, Advani Anjali S, Duong Hien K, Copelan Edward, Kapur Reuben, Olalla Saad Sara T, Maciejewski Jaroslaw P, Tiu Ramon |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 10, 2022
- Content source: